Profex

Name

Profex

Website

https://profex.com

Company type

Private

Founded year

2001

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Dermatology Pharmaceutical Distribution

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Dermatology Specialty Pharmaceuticals (HLAIACAL)

akta.pro secondary industries

General & Medical Dermatology (HLAKACAA), Dermatology & Topical Skin Treatments (HLAIADAE), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• Dermatology products
• Skin therapeutics
• Pharmaceutical distribution
• Dermatological drugs
• Medical dermatology

Headquarters

HQ city

Zhongxin

HQ country

China

HQ region

Asia

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel

Core offering

Profex is an international dermatology company that distributes dermatological drugs to Chinese dermatologists, patients, and consumers. Its current portfolio includes a product referenced as "Titan," hosted on the company website profex.com, serving both clinical and consumer dermatology needs in China.

Differentiator

Problem solved

Functional benefit

Products and services

• Titan Titan is a product referenced by Profex on its company website (http://profex.com/) in the context of distributing dermatological drugs to Chinese dermatologists, patients, and consumers. Specific functional details about the product are not provided in the source material.
• Dermatological drug distribution in China International dermatology company distributing dermatological drugs to dermatologists, patients, and consumers in China. The product serves both clinical prescribers (B2B) and consumer end-buyers (B2C).

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• LEO Pharma: Global specialty dermatology pharmaceutical company marketing prescription and OTC dermatology treatments. Comparable to Profex as a dermatology-focused pharma player, though LEO Pharma owns its own product portfolio while Profex distributes in China.
• Galderma: Pure-play dermatology company with prescription, aesthetic, and consumer skincare products. Highly comparable category focus to Profex, though Galderma is a global branded manufacturer rather than a China-focused distributor.
• Almirall: European specialty dermatology pharmaceutical company with a focused portfolio across medical and aesthetic dermatology. Comparable as a dermatology-specialized pharma player serving prescribers and consumers.

Regional players

• Shanghai Fosun Pharmaceutical: Large Chinese pharmaceutical group with dermatology and consumer health segments. Comparable as a China-based pharma player serving dermatologists, but operates at significantly larger scale across many therapeutic areas.
• Huapont Life Sciences: Chinese dermatology-focused pharmaceutical company with branded prescription and OTC skin products. Closest direct China-based dermatology specialty comparable to Profex.

Broad incumbents

• Bayer (Consumer Health / Dermatology): Diversified life sciences company with a meaningful dermatology and skincare consumer health portfolio. Comparable in dermatology category, though dermatology is one segment within a much larger conglomerate.
• Pierre Fabre Dermatologie: French pharmaceutical group with a leading dermatology division (prescription, dermo-cosmetics, and medical skincare). Comparable as a dermatology-specialized player spanning pharma and dermocosmetics.
• China Resources Pharmaceutical (Sinopharm): China's largest state-linked pharmaceutical distributor and manufacturer with broad therapeutic coverage including dermatology. Comparable as a China-based pharma distribution platform competing for dermatologist channel access.

Emerging players

• Sun Pharma: Indian specialty pharma with a notable dermatology franchise and growing international presence. Comparable category focus, with expanding global distribution ambitions including emerging markets.
• Dermavant Sciences: Specialty dermatology biotech focused on innovative topical therapies. Less directly comparable as a development-stage company, but highly relevant as a potential partner or licensor of dermatology assets seeking China distribution.

Market position

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Profex